1Frei E 3rd.Clinical cancer research:an embattled species[J].Cancer,1982,50 (10):1979-1992.
2Wiike H,Preuser P,Fink U,et al.Peoperative chemotherapy in locally advanced and nonresectable gastric cancer:a phase II study with etoposide,doxorubicin,and cisplatin[J].J chin Oncol,1989,7(9):1318-1326.
3Mai M,Takahashi Y,Fujimoto T,et al.Neoadjuvomt chemotherapy for far-advanced gastric carcinoma[J].Gan To Kagaku Ryoho,1994,21(4):431-439.
4Macdonald JS.Clinical overview:adjuvant therapy of gastrointestional cancer[J].Cancer chemother pharmacol,2004,54(suppl 1):S4-11.
5Hartgrink HH,Van de velder CJ,putter H,et al.Neo-adjuvant chemotherapy for operable gastric cancer:long term results of the Dutch randomised FAMTX trial[J].Eur J Sung Oncol,2004,30(6):643-649.
6Cascinu S,Gra ziano F,Barni S,et al.Hxdro-dynamic CT preoperative staging of gastris cancer corrlation with pathological findings,A prospective study 05 107 cases[J].Eur Radiol,2002,10(12):1877-1885.
7Kue LJ,Chern MC,Tsou MH,et al.Interpretation of magnetic resonance imaging for locally advanced rectal Corcinoma after preoperative chemoradiation therapy[J].Dis colon Rectum,2005,48(1):23-28.
9Sugarbaker PH,Cunliffe WJ,Belliveau J,et al.Rationale for intergrating early postoperative Intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer[J].Semin Oncol,1989,16(1):83.
10Kim JP,Yu HJ,Lee JH,et al.Results of ummunocheno-Surgery for gastric Carcinoma,Hepatogastrienter ology,2001,48:1227-1230.
二级参考文献5
1Elias D,El Otmany A,Bonnay M,et al.Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis.Oncology,2002,63:346-352.
2Witkamp AJ,de Bree E,Van Goethem R,et al.Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.Cancer Treat Rev,2001,27:365-374.
4Stephen RL,Novak JM,Jensen EM,et al.Effect of osmotic pressure on uptake of chemotherapeutic agents by carcinoma cells.Cancer Res,1990,50:4704-4708.
5Tsujitani S,Oka A,Kondo A,et al.Administration in a hypotonic solution is preferable to dose escalation in intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in rats.Oncology,1999,57:77-82.
